President Trump signed an EO last week that directs federal agencies to reschedule cannabis. The move will benefit US MSOs, including Cresco Labs, because they will be free of the 280e tax burden.
CHICAGO, December 18, 2025--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie ...
MediPharm Labs ( (TSE:LABS)) has issued an update. MediPharm Labs is positioning itself to capitalize on the U.S. decision to reclassify cannabis from Schedule I to Schedule III, a move that ...
Colorado’s cannabis industry ended 2025 with a vast recall hitting nearly 300 dispensaries.
TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a ...
Where do the well-known cannabis compounds THC, CBD and CBC come from? Researchers at Wageningen University & Research have ...
As Michigan’s recreational cannabis industry begins its seventh year this year, cannabis customers have more choices than ...
The latest announcement is out from Cresco Labs ( (TSE:CL)). Cresco Labs has welcomed the U.S. federal government’s decision to move cannabis from Schedule I to Schedule III, calling it the most ...
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana. Reports first emerged last week that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback